Skip to main content
P

Protogenix

Protogenix engineers novel proteins with tailored functionalities for therapeutic, industrial, and biomaterial applications. Our proprietary computational design and high-throughput screening platforms accelerate the development of custom proteins with enhanced efficacy, stability, and specificity.

Schiltigheim, FranceFounded 2003463K+ followers
Updated 4 months ago

Funding

$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Developing novel protein-based solutions for diverse applications presents significant challenges in protein engineering and design. The current landscape often lacks specialized tools and methodologies to efficiently create and optimize proteins with desired functionalities for scientific research and industrial processes.

Solution

Protogenix is a biotechnology company specializing in advanced protein engineering and development. We leverage proprietary computational design platforms and high-throughput screening methodologies to engineer novel proteins with tailored functionalities. Our approach focuses on creating bespoke protein therapeutics, industrial enzymes, and biomaterials that address specific performance requirements. By integrating in silico protein modeling with in vitro validation, we accelerate the discovery and optimization cycle for protein-based innovations. This allows us to deliver custom protein solutions that enhance efficacy, stability, and specificity for a wide range of applications.

Target Audience

Our primary customers include pharmaceutical companies, agricultural technology firms, and research institutions requiring custom protein solutions for drug discovery, enzyme development, and advanced biomaterials.

Features

  • Computational protein design engine utilizing advanced algorithms for de novo protein structure and sequence generation.
  • High-throughput screening platforms for rapid functional characterization and selection of engineered proteins.
  • Directed evolution techniques to optimize protein properties such as catalytic activity, binding affinity, and stability.
  • Expertise in protein expression and purification across various host systems, including bacterial, yeast, and mammalian cells.
  • Structure-function relationship analysis to guide protein engineering strategies.
  • Development of protein-based therapeutics, including antibodies and enzymes, for targeted biological interventions.
  • Engineering of industrial enzymes for improved performance in bioprocessing and manufacturing.
This profile is AI-generated and may contain inaccuracies.